EQS-News: MorphoSys' Pelabresib Improves All Four Hallmarks

EQS-News: MorphoSys AG / Key word(s): Conference MorphoSys’ Pelabresib Improves All Four Hallmarks of Myelofibrosis in...

Related Keywords

California , United States , London , City Of , United Kingdom , Massachusetts , San Diego , Boston , Planegg , Bayern , Germany , American , Eamonn Nolan , Raajitk Rampal , Tim Demuth , Thomas Biegi , Julia Neugebauer , Ruben Mesa , Claire Harrison , Memorial Sloan Kettering Cancer Center , Drug Administration , European Medicines Agency , Exchange Commission , Twitter , Hilton San Diego Bayfront Hotel , Nasdaq , Myeloproliferative Neoplasms Program , Lymphoma Society , Linkedin , Atrium Health Levine Cancer Center , American Society Of Hematology , Constellation Pharmaceuticals Inc , Development Officer , American Society , Annual Meeting , Hematologic Malignancies , Memorial Sloan Kettering Cancer , Spleen Size , Professor Claire Harrison , Bone Marrow , Morphosys Chief Research , Executive Director , Morphosy Annual Report ,